Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
Breast Cancer Research and Treatment|January 5, 2002
An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancerH Bonnefoi, L Biganzoli, T Cufer, et al.International Journal of Radiation Oncology, Biology, Physics|June 2, 1998
Invasive bladder cancer: our experience with bladder sparing approachJ Cervek, T Cufer, B Zakotnik, et al.Cytopathology : Official Journal of the British Society for Clinical Cytology|December 12, 2007
S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patientsB Gazic, J Pizem, M Bracko, et al.European Journal of Cancer (Oxford, England : 1990)|April 9, 2002
An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanesA Awada, L Biganzoli, T Cufer, et al.Anti-Cancer Drugs|August 1, 1995
Cyclosporine A increases serum cortisol levels in rabbitsT Cufer, I Vrhovec, J Skrk, et al.Cancer Investigation|February 20, 2014
Association of aromatase inhibitors with coronary heart disease in women with early breast cancerB Seruga, V Zadnik, C Grasic Kuhar, et al.Magyar Onkologia|September 5, 2015
[Molecular diagnostics of lung cancer]A Ryska, R Dziadziuszko, W Olszewski, et al.Anti-Cancer Drugs|July 18, 2000
Decreased cortisol secretion by adrenal glands perfused with the P-glycoprotein inhibitor valspodar and mitotane or doxorubicinT Cufer, M Pfeifer, I Vrhovec, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAKK multicenter studyP Therasse, L Mauriac, M Welnicka-Jaskiewicz, et al.Breast (Edinburgh, Scotland)|September 29, 2005
Adjuvant chemotherapy in 2005: standards and beyondM J Piccart, D de Valeriola, L Dal Lago, et al.Pageof 5